Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia

被引:9
作者
Tilahun, Melaku [1 ,2 ]
Shimelis, Ezra [1 ,3 ]
Wogayehu, Teklu [2 ]
Assefa, Gebeyehu [1 ]
Wondimagegn, Getachew [4 ]
Mekonnen, Alemayehu [5 ]
Hailu, Tsegaye [1 ]
Bobosha, Kidist [1 ]
Aseffa, Abraham [1 ]
机构
[1] Armauer Hansen Res Inst AHRI, Addis Ababa, Ethiopia
[2] Arba Minch Univ AMU, Dept Biol, Coll Nat Sci, Arba Minch, Ethiopia
[3] Addis Ababa Univ AAU, Sch Publ Hlth, Black Lion Hosp, Coll Hlth Sci, Addis Ababa, Ethiopia
[4] KNCV TB Fdn, Addis Ababa, Ethiopia
[5] Ethiopian Publ Hlth Assoc, Addis Ababa, Ethiopia
关键词
MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS;
D O I
10.1371/journal.pone.0236054
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Multi-drug resistance is a major challenge in the control of tuberculosis. Despite newer modalities for diagnosis and treatment, people are still suffering from this disease. Understanding the common gene mutations conferring rifampicin and isoniazid resistance is crucial for the implementation of effective molecular tools at local and national levels. Hence, this study aimed to evaluate the molecular detection of rifampicin and isoniazid-resistant gene mutations inM.tuberculosisisolates in Addis Ababa, Ethiopia. Method Health Center-based cross-sectional study was conducted between January and September 2017 in Addis Ababa, Ethiopia. The collected sputum samples were processed for mycobacterial isolation and Region of difference 9 based polymerase chain reaction for species identification. To characterize the rifampicin and isoniazid-resistantM.tuberculosisisolates, a molecular genetic assay (GenoType MTBDRplus) was used; the assay is based on DNA-STRIP technology. Result Culture positivity was confirmed in 82.6% (190/230) of smear-positive newly diagnosed pulmonary tuberculosis cases enrolled in the study. From 190 isolates 93.2% were sensitive for both rifampicin and isoniazid, and 6.8% of the isolates were resistant to at least one of the tested anti-TB drugs. Gene mutations were observed in all studied multidrug resistance-associated gene loci (rpoB,katG, andinhA). Two isolates exhibited heteroresistance, a mutated, as well as wild type sequences, were detected in the respective strains. MDR-TB case was observed in 1.1% (2/190) of the cases. All the MDR-TB cases were positive for HIV and found to have a history of prior hospital admission. Conclusion In our finding a relatively high prevalence of any drug resistance was observed and the overall prevalence of multidrug-resistant tuberculosis was 1.1%.The majority of drug-resistant isolates demonstrated common mutations. Heteroresistant strains were detected, signaling the existence of anM.tuberculosispopulation with variable responses to anti-tuberculosis drugs or of mixed infections.
引用
收藏
页数:14
相关论文
共 39 条
[1]   lsoniazid and rifampicin resistance mutations and their effect on second-line anti-tuberculosis treatment [J].
Abate, D. ;
Tedla, Y. ;
Meressa, D. ;
Ameni, G. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (08) :946-951
[2]   Prevalence of Smear-Positive Tuberculosis among Patients Who Visited Saint Paul's Specialized Hospital in Addis Ababa, Ethiopia [J].
Abera Nugussie, Dinna ;
Ali Mohammed, Getachew ;
Tesfaye Tefera, Anteneh .
BIOMED RESEARCH INTERNATIONAL, 2017, 2017
[3]   Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia [J].
Alelign, Amir ;
Zewude, Aboma ;
Mohammed, Temesgen ;
Tolosa, Samuel ;
Ameni, Gobena ;
Petros, Beyene .
BMC INFECTIOUS DISEASES, 2019, 19 (1)
[4]  
[Anonymous], POP PROJ ETH ALL REG
[5]  
[Anonymous], GUID QUAL ASS SMEAR
[6]  
[Anonymous], 2012, GenoType MTBDR plus. VER 2.0, instructions for use, IFU-304A-02
[7]   Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia [J].
Brhane, Mussie ;
Kebede, Ameha ;
Petros, Yohannes .
INFECTION AND DRUG RESISTANCE, 2017, 10 :75-83
[8]   Genetic diversity and drug susceptibility profiles of Mycobacterium tuberculosis obtained from Saint Peter's TB specialized Hospital, Ethiopia [J].
Damena, Delesa ;
Tolosa, Samuel ;
Hailemariam, Milkessa ;
Zewude, Aboma ;
Worku, Adane ;
Mekonnen, Biruk ;
Mohammed, Temesgen ;
Admasu, Addisu ;
Chimusa, Emile R. ;
Mihret, Adane ;
Abebe, Tamrat ;
Ameni, Gobena .
PLOS ONE, 2019, 14 (06)
[9]   HIV and multidrug-resistant tuberculosis: overlapping epidemics [J].
Dean, Anna S. ;
Zignol, Matteo ;
Falzon, Dennis ;
Getahun, Haileyesus ;
Floyd, Katherine .
EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (01) :251-254
[10]  
Desalegn DM, 2019, AFR J LAB MED, V8